%0 Journal Article
%T Nutraceutical Supplementation Based on Colostrum as Osteoporosis Treatment:  A Pilot Study
%A Styliani Ziaka
%A Tania Amorim
%A Maria Vliora
%A Paraskevi Gkiata
%A Konstantinos Mantzios
%A Georgia Ntina
%A Eirini K.Kydonaki
%A Vasileios Gkizlis
%A Yiannis Koutedakis
%J Food and Nutrition Sciences
%P 659-669
%@ 2157-9458
%D 2021
%I Scientific Research Publishing
%R 10.4236/fns.2021.127049
%X <strong>Introduction</strong>:<span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\"> Naturally based treatments for osteoporosis are
currently limited. The purpose of this investigation was to ascertain whether
bovine colostrum supplementation can improve bone health in humans. </span><b><span style=\"font-family:Verdana;\">Methods:</span></b><span style=\"font-family:Verdana;\"> In tot</span><span style=\"font-family:Verdana;\"></span><span style=\"font-family:Verdana;\">al 63 individuals volunteered in a 4-month supplementation project. They
were stratified into three groups: </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">1</span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">) healthy post-menopausal women (n = 24)</span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">;</span></span><span><span style=\"font-family:;\" \"=\"\"> </span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">2</span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">) individuals with osteopenia (n = 25)</span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">;</span></span><span><span style=\"font-family:;\" \"=\"\"> </span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">3</span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">) people with osteoporosis (n = 14). Participants of each group were
randomly assigned into two experimental sub-groups: </span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">a</span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">) the bovine colostrum (BC) supplementation (200</span></span><span><span style=\"font-family:;\" \"=\"\"> </span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">mL/day; 5 days/week)</span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">;</span></span><span><span style=\"font-family:;\" \"=\"\"> </span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">b</span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">) the placebo sub-group. Before and after the 4-month supplementation,
blood samples were obtained and bone mineral density (BMD) was measured. Dual-Energy
X-ray Absorptiometry (DXA) was performed on three different anatomical
%K Nutraceutical Supplementation
%K Bone Nutrients
%K Osteoporosis
%K Bovine Colostrum
%K Post-Menopausal Women
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=110385